Preclinical Development of ARV-2001, an Intradermally Administered mRNA-Lipid Nanoparticle Immunotherapeutic for the Treatment of HPV-16-Positive Cervical High-Grade Squamous Intraepithelial Lesions.

Zhengxiang He, Huabin Zhu, Ju Hyeong Jeon, Jianzhu Chen, Gregory M Glenn, Renhuan Xu

Abstract read

In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhengxiang HePinion Immunotherapeutics, North Bethesda, MD 20852, USA.ORCID 0000-0002-8961-859X

Huabin ZhuPinion Immunotherapeutics, North Bethesda, MD 20852, USA.

Ju Hyeong JeonPinion Immunotherapeutics, North Bethesda, MD 20852, USA.

Jianzhu ChenDepartment of Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.ORCID 0000-0002-5687-6154

Gregory M GlennPinion Immunotherapeutics, North Bethesda, MD 20852, USA.

Renhuan XuPinion Immunotherapeutics, North Bethesda, MD 20852, USA.ORCID 0000-0001-6817-1875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cervical high-grade squamous intraepithelial lesionHPV16intradermal injectionmRNA vaccineTC-1 tumor modelT-cell immunity

Identifiers

PMID42646731

DOI10.3390/vaccines14080714

PMCPMC13517577

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.